ATE386724T1 - Substituierte hexahydrobenzo(a) phenanthridine - Google Patents
Substituierte hexahydrobenzo(a) phenanthridineInfo
- Publication number
- ATE386724T1 ATE386724T1 AT93914148T AT93914148T ATE386724T1 AT E386724 T1 ATE386724 T1 AT E386724T1 AT 93914148 T AT93914148 T AT 93914148T AT 93914148 T AT93914148 T AT 93914148T AT E386724 T1 ATE386724 T1 AT E386724T1
- Authority
- AT
- Austria
- Prior art keywords
- phenanthridine
- hydrogen
- group
- hexahydrobenzo
- iodo
- Prior art date
Links
- VYSFAJWUEDDBOJ-UHFFFAOYSA-N 1,2,3,4,4a,5-hexahydrobenzo[a]phenanthridine Chemical class C1=CC=C2C=CC3=NCC(CCCC4)C4=C3C2=C1 VYSFAJWUEDDBOJ-UHFFFAOYSA-N 0.000 title 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 4
- 239000001257 hydrogen Substances 0.000 abstract 4
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 4
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 2
- -1 chloro, bromo, iodo Chemical group 0.000 abstract 2
- 125000001153 fluoro group Chemical group F* 0.000 abstract 2
- 102000015554 Dopamine receptor Human genes 0.000 abstract 1
- 108050004812 Dopamine receptor Proteins 0.000 abstract 1
- 239000003446 ligand Substances 0.000 abstract 1
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
- C07D221/18—Ring systems of four or more rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychiatry (AREA)
- Cardiology (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US88769292A | 1992-05-26 | 1992-05-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE386724T1 true ATE386724T1 (de) | 2008-03-15 |
Family
ID=25391659
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT93914148T ATE386724T1 (de) | 1992-05-26 | 1993-05-26 | Substituierte hexahydrobenzo(a) phenanthridine |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US5420134A (de) |
| EP (1) | EP0644877B1 (de) |
| JP (1) | JP3476193B2 (de) |
| KR (1) | KR100292928B1 (de) |
| AT (1) | ATE386724T1 (de) |
| AU (1) | AU4391493A (de) |
| DE (1) | DE69334206D1 (de) |
| WO (1) | WO1993024462A1 (de) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI954738A7 (fi) * | 1993-04-06 | 1995-12-05 | Abbott Lab | Tetrasykliini yhdisteet dopamiiniagonisteina |
| US5744476A (en) * | 1994-06-27 | 1998-04-28 | Interneuron Pharmaceuticals, Inc. | Dopamine D1 agonists for the treatment of dementia |
| EP0773933A1 (de) * | 1994-07-15 | 1997-05-21 | Purdue Research Foundation | Optisch aktive isomere des dihydrexidin und substituierte analoge davon |
| US5659037A (en) * | 1994-08-18 | 1997-08-19 | Abbott Laboratories | Process for preparing chiral tetracyclic dopaminergic compounds |
| MX9801179A (es) * | 1995-08-18 | 1998-04-30 | Purdue Research Foundation | Isoquinolinas fusionadas, novedosas como ligandos del receptor de dopamina. |
| US5668141A (en) * | 1996-04-02 | 1997-09-16 | Abbott Laboratories | Trans-2,6-,3,6-and 4,6-diaza-5,6,6a,7,8,12b-hexahydrobenzo[c]phenanthrene compounds as dopamine agonists |
| US6541669B1 (en) * | 1998-06-08 | 2003-04-01 | Theravance, Inc. | β2-adrenergic receptor agonists |
| EP1414457B1 (de) * | 2001-08-10 | 2007-06-20 | Purdue Research Foundation | Chirales dinapsolin |
| DE60323339D1 (de) * | 2002-02-15 | 2008-10-16 | Darpharma Inc | Monoester und asymmetrisch substituierte diester prodrugs der dopamin-d1-rezeptor-agonisten |
| EP1699450A4 (de) * | 2003-12-23 | 2009-11-11 | Darpharma Inc | Gleichzeitige verabreichung von dopamin-rezeptor-bindungsverbindungen |
| NZ570606A (en) * | 2006-02-21 | 2011-11-25 | Purdue Research Foundation | Trans-fused chromenoisoquinolines, synthesis and methods for use |
| WO2010017093A2 (en) * | 2008-08-05 | 2010-02-11 | Effipharma, Inc. | Dopamine receptor ligands with enhanced duration of action |
| WO2010124005A1 (en) | 2009-04-21 | 2010-10-28 | Purdue Research Foundation | Octahydrobenzoisoquinoline modulators of dopamine receptors and uses therefor |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3912740A (en) * | 1974-02-28 | 1975-10-14 | Us Health | Method for the preparation of oxygenated benzo{8 c{9 phenanthridine compounds |
| US3939165A (en) * | 1974-11-14 | 1976-02-17 | Morton-Norwich Products, Inc. | 5,6,6A,6B,7,8-Hexahydrobenz[a]phenanthridine hydrochloride |
| US4737503A (en) * | 1986-10-08 | 1988-04-12 | Vipont Laboratories, Inc. | Method for inhibiting the release of histamine |
| US5047536A (en) * | 1989-03-17 | 1991-09-10 | Purdue Research Foundation | Hexahydrobenzo(A)phenanthridine compounds |
| IE912999A1 (en) * | 1990-09-07 | 1992-03-11 | Abbott Lab | Phenanthridine compounds |
-
1993
- 1993-05-26 WO PCT/US1993/004971 patent/WO1993024462A1/en not_active Ceased
- 1993-05-26 AU AU43914/93A patent/AU4391493A/en not_active Abandoned
- 1993-05-26 JP JP50072094A patent/JP3476193B2/ja not_active Expired - Fee Related
- 1993-05-26 KR KR1019940704219A patent/KR100292928B1/ko not_active Expired - Fee Related
- 1993-05-26 EP EP93914148A patent/EP0644877B1/de not_active Expired - Lifetime
- 1993-05-26 DE DE69334206T patent/DE69334206D1/de not_active Expired - Lifetime
- 1993-05-26 AT AT93914148T patent/ATE386724T1/de not_active IP Right Cessation
- 1993-09-30 US US08/129,810 patent/US5420134A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| JP3476193B2 (ja) | 2003-12-10 |
| KR100292928B1 (ko) | 2001-11-05 |
| DE69334206D1 (de) | 2008-04-03 |
| WO1993024462A1 (en) | 1993-12-09 |
| EP0644877B1 (de) | 2008-02-20 |
| KR950701623A (ko) | 1995-04-28 |
| US5420134A (en) | 1995-05-30 |
| EP0644877A4 (de) | 1995-02-03 |
| JPH07507313A (ja) | 1995-08-10 |
| EP0644877A1 (de) | 1995-03-29 |
| AU4391493A (en) | 1993-12-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE386724T1 (de) | Substituierte hexahydrobenzo(a) phenanthridine | |
| ATE22084T1 (de) | Ester von phosphinylalkanoyl-substituierten prolinen. | |
| SE8704599D0 (sv) | Teobrominderivat | |
| ATE12224T1 (de) | Verbindungen mit antifibrinolytischer wirksamkeit. | |
| DK0607400T3 (da) | Fluorerede 17beta-substituerede 4-aza-5-alfa-androstan-3-on-derivater | |
| ES2122258T3 (es) | 4-azaesteroides 15 sustituidos. | |
| ATE42541T1 (de) | Methyl-benzoylamino-2-hydroxy-acetate. | |
| ES8705425A1 (es) | Un compuesto. | |
| TW337985B (en) | "N-(B-branched alkyl)-1, 2-benzisothiolin, 3ones, their preparation and their use as industrial biocides" | |
| ES2078876A1 (es) | Una composicion herbicida a base de fenilpirazol 3-sustituidos. | |
| YU142791A (sh) | Heterociklična jedinjenja | |
| DK0689534T3 (da) | Amidderivater som 5-HT1A-ligander | |
| UA43338C2 (uk) | Похідні бензолу | |
| HUT78061A (hu) | Eljárás 2-(aril-oxi)-4-klór-piridin-származékok előállítására | |
| CA2135926A1 (en) | Substituted hexahydrobenzo[a]phenanthridines | |
| TW334337B (en) | Preparation and composition for a compound of controlling and preventing phytopathogenic fungi | |
| DK0782574T3 (da) | Bicycliske carboxiamider som 5-HT1A-receptorligander | |
| ES2103675A1 (es) | Nuevas piperidinas sustituidas. | |
| DE69217148D1 (de) | Isoxazole derivate als lichtschutzmittel | |
| ES8800663A1 (es) | Procedimiento para preparar compuestos arilsulfonicos. | |
| AR248401A1 (es) | Un microbiocida de 3-halo-5-halometil-2-oxazolidinona, su preparacion e intermediario 5-halometil-2-oxazolidinona y control de un microorganismo en un sistema acuoso y sobre una superficie. | |
| ES8107202A1 (es) | Procedimiento para preparar nuevos derivados de oxadiazolin-1,3,4-ona-5. | |
| MX9707201A (es) | Derivados de 1-carba-(detia)-cefalosporina. | |
| MX9801963A (es) | Derivados de benzotiazolona. | |
| TH36107A (th) | สารประกอบชนิดใหม่ |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |